1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,109 | 0,149 | 30.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
| Mo | hVIVO reports positive results from Cidara's Phase 2b influenza study | 2 | Investing.com | ||
| Mo | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
| 05.06. | hVIVO PLC - Result of AGM | - | RNS | ||
| 02.06. | DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock | 2 | Alliance News | ||
| 02.06. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 30.05. | hVIVO stock plunges after contract cancellations in 'depressed' market | 1 | Alliance News | ||
| 30.05. | Hvivo shares tank after contract cancellations | 4 | Shares | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 30.05. | AIM WINNERS & LOSERS: hVIVO shares dive on contract cancellations | 1 | Alliance News | ||
| 30.05. | Hvivo client cancels 'significant' HCT trial contract | 1 | Sharecast | ||
| 30.05. | hVIVO PLC - Trading update | - | RNS | ||
| 29.05. | hVIVO PLC - Appointment of Independent Non-Executive Director | - | RNS | ||
| 12.05. | hVIVO announces annual report and upcoming AGM | 1 | Investing.com | ||
| 12.05. | hVIVO kündigt Jahresbericht und kommende Hauptversammlung an | 1 | Investing.com Deutsch | ||
| 12.05. | hVIVO PLC - Annual Report, Notice of AGM & Directorate Change | - | RNS | ||
| 10.04. | EARNINGS AND TRADING: Castelnau swings to profit; hVIVO sees growth | 2 | Alliance News | ||
| 10.04. | hVivo reports record full-year revenue, earnings | 1 | Sharecast | ||
| 10.04. | hVivo's chairman Cathal Friel not seeking re-election | 2 | RTE.ie | ||
| 10.04. | hVIVO PLC - Exercise of Options | - | RNS | ||
| 10.04. | hVIVO PLC - Final results | - | RNS |
1 2 3 Weiter >>
49 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,347 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ in Leptomeningeal Metastases | Primary objective to determine optimal dosing schedule for a registrational trial Trial builds on recommended Phase 2 dose determined in completed Phase 1 trial Trial benefits from $17.6M award... ► Artikel lesen | |
| LIFEWARD | 0,643 | 0,00 % | Lifeward Ltd.: Administrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare Beneficiary | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| JD HEALTH | 4,600 | 0,00 % | JD Health-Aktie: Kurs heute im Minus (4,38 €) | Im Wertpapierhandel notiert die JD Health-Aktie derzeit etwas leichter. Die Aktie notiert zur Stunde bei 4,38 Euro. Am Aktienmarkt liegt das Wertpapier von JD Health gegenwärtig im Minus. Das Papier... ► Artikel lesen | |
| EKSO BIONICS | 3,280 | 0,00 % | XFRA 23E0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEKSO BIONICS. NEW... ► Artikel lesen | |
| IMUNON | 0,685 | +0,74 % | Imunon, Inc.: IMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025 | ASCO 2025 overall survival data bolster IMNN-001's potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,710 | -1,05 % | ROCKWELL MEDICAL, INC. - 8-K, Current Report | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 12,000 | +1,14 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
| SINTX TECHNOLOGIES | 3,200 | 0,00 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
| AETHLON MEDICAL | 1,430 | -100,00 % | Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update | Three Patients Treated in Hemopurifier® Cancer Trial; Indian Regulatory Approval Achieved; Operating Expenses Reduced; R&D Advances Support Expanded Indications... ► Artikel lesen | |
| NEURONETICS | 2,950 | -0,34 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero, ElevationMD use Aristotle to detect cancer | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| SAVARIA | 12,100 | -0,82 % | Dividendenbekanntmachungen (30.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIA REALTY TRUST US0042391096 0,2 USD 0,1706 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1808 EUR ADVANCED FLOWER CAPITAL... ► Artikel lesen | |
| IMAC HOLDINGS | 0,192 | -4,00 % | IMAC Holdings, Inc. - 10-K/A, Annual Report |
Das Unternehmen HVIVO PLC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,56 % bei einem Aktienkurs von 0,114 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.